Market Overview: The global market for eukaryotic expression systems was valued at USD 3.66 billion in 2022 and is projected to reach USD 7.44 billion by 2032, with an estimated compound annual growth rate (CAGR) of 8.2% over the forecast period. Key drivers of market growth include the increasing prevalence of chronic diseases, a growing demand for biopharmaceuticals, and advancements in gene...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian